Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Specialty Chemicals

Alto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. It operates in two segments, Production and Marketing. The company offers specialty alcohols used in mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and cleaners; alcoholic beverages, flavor extracts, and vinegar, as well as corn germ used for corn oils and carbon dioxide. It also provides essential ingredients, such as dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed used in commercial animal feed and pet food; and fuel-grade ethanol used as transportation fuel and distillers corn oil used as a biodiesel feedstock, as well as fuel-grade ethanol produced by third parties. In addition, the company offers transportation, storage, and delivery services through third-party service providers. It sells ethanol to integrated oil companies and gasoline marketers; essential ingredient feed products to dairies and feedlots; and corn oil to poultry and biodiesel customers. The company operates seven ethanol production facilities, including three plants in the Midwestern states of Illinois; and four plants located in the Western states of California, Oregon, and Idaho. The company was formerly known as Pacific Ethanol, Inc. and changed its name to Alto Ingredients, Inc...
Website: altoingredients.com


  • Good financial results growth rate 79.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-6.8%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -5.5% (LTM)
  • Share price is 240.5% higher than minimum and 45.9% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 30.0x)

Key Financials (Download financials)

Ticker: ALTO
Share price, USD:  (0.0%)2.66
year average price 1.41  


year start price 1.67 2025-01-11

min close price 0.78 2025-04-21

max close price 3.08 2025-12-24

current price 2.66 2026-01-10
Common stocks: 74 777 000

Dividend Yield:  0.0%
Last revenue growth (y/y):  -4.4%
Last growth of EBITDA (y/y):  +163.6%
Historical revenue growth:  -12.4%
Historical growth of EBITDA:  -1.2%
EV / Sales: 0.3x
Margin (EBITDA LTM / Revenue): -0.9%

Target EV / EBITDA (hist percentile): 30.0x
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 199
Net Debt ($m): 84
EV (Enterprise Value): 283
EBITDA LTM (млн $): -8
Price to Book: 0.9x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-31zacks.com

Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?

2025-12-15zacks.com

Are Consumer Discretionary Stocks Lagging Alto Ingredients (ALTO) This Year?

2025-11-27zacks.com

Is Alto Ingredients (ALTO) Stock Outpacing Its Consumer Discretionary Peers This Year?

2025-11-12zacks.com

Alto Ingredients (ALTO) Just Flashed Golden Cross Signal: Do You Buy?

2025-11-11zacks.com

Is Alto Ingredients (ALTO) Outperforming Other Consumer Discretionary Stocks This Year?

2025-11-05zacks.com

Alto Ingredients (ALTO) Q3 Earnings and Revenues Surpass Estimates

2025-10-20businesswire.com

Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting

2025-10-07globenewswire.com

ALTO ALERT: Bragar Eagel & Squire, P.C. is Investigating Alto Neuroscience, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2025-06-26businesswire.com

Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203

2025-05-07seekingalpha.com

Alto Ingredients, Inc. (ALTO) Q1 2025 Earnings Call Transcript
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164
fillingDate 2025-11-07 2025-08-08 2024-11-08 2024-08-08 2024-05-08 2024-03-14 2023-11-08 2023-08-08 2023-05-09 2023-03-14 2022-11-09
acceptedDate 2025-11-07 16:16:19 2025-08-08 16:11:46 2024-11-08 16:20:26 2024-08-08 16:35:14 2024-05-08 16:15:43 2024-03-14 06:20:03 2023-11-08 16:32:32 2023-08-08 16:16:45 2023-05-09 16:36:10 2023-03-14 16:36:21 2022-11-08 20:38:21
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 241M 218M 252M 236M 241M 274M 318M 317M 314M 328M 337M
costOfRevenue 217M 220M 246M 232M 240M 274M 314M 300M 317M 350M 357M
grossProfit 23M -2M 6M 5M 938 000 9000 4M 17M -3M -21M -20M
grossProfitRatio 0.097 -0.009 0.024 0.02 0.004 0 0.013 0.054 -0.01 -0.065 -0.059
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 7M 6M 8M 9M 8M 9M 8M 8M 8M 8M 7M
otherExpenses 0 0 0 -29 000 241 000 449 000 26 000 59 000 19 000 930 000 0
operatingExpenses 7M 6M 8M 9M 8M 9M 6M 8M 8M 8M 7M
costAndExpenses 224M 227M 253M 241M 248M 282M 320M 308M 325M 357M 364M
interestIncome 0 0 0 0 0 -5M 2M 2M 0 0 0
interestExpense 3M 3M 2M 2M -2M 2M 2M 2M 2M 968 000 340 000
depreciationAndAmortization 6M 6M 6M 6M 6M 6M 3M 6M 593 000 3M -456 000
ebitda 23M -2M 5M 5M -1M -3M -1M 15M -11M -28M -28M
ebitdaratio 0.097 -0.008 0.022 0.008 -0.005 -0.01 -0.005 0.047 -0.035 -0.085 -0.082
operatingIncome 17M -8M -720 000 -4M -7M -9M -4M 9M -12M -31M -27M
operatingIncomeRatio 0.07 -0.037 -0.003 -0.018 -0.029 -0.031 -0.014 0.029 -0.037 -0.095 -0.081
totalOtherIncomeExpensesNet -3M -3M -2M -2M -5M -10M 26 000 59 000 -2M -38 000 -796 000
incomeBeforeTax 14M -11M -2M -3M -12M -19M -3M 8M -13M -31M -28M
incomeBeforeTaxRatio 0.059 -0.05 -0.01 -0.013 -0.049 -0.069 -0.011 0.024 -0.042 -0.095 -0.083
incomeTaxExpense 0 0 0 0 6M 97 000 -812 000 2M -5M 2M -6M
netIncome 14M -11M -2M -3M -12M -19M -3M 8M -8M -33M -22M
netIncomeRatio 0.059 -0.05 -0.01 -0.013 -0.049 -0.069 -0.011 0.024 -0.024 -0.101 -0.065
eps 0.19 -0.15 -0.037 -0.042 -0.16 -0.26 -0.048 0.1 -0.1 -0.45 -0.3
epsdiluted 0.19 -0.15 -0.037 -0.042 -0.16 -0.26 -0.048 0.1 -0.1 -0.45 -0.3
weightedAverageShsOut 74M 74M 74M 73M 73M 73M 73M 74M 74M 73M 73M
weightedAverageShsOutDil 74M 74M 74M 73M 73M 73M 73M 74M 74M 73M 73M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164
fillingDate 2025-11-07 2025-08-08 2024-11-08 2024-08-08 2024-05-08 2024-03-14 2023-11-08 2023-08-08 2023-05-09 2023-03-14 2022-11-09
acceptedDate 2025-11-07 16:16:19 2025-08-08 16:11:46 2024-11-08 16:20:26 2024-08-08 16:35:14 2024-05-08 16:15:43 2024-03-14 06:20:03 2023-11-08 16:32:32 2023-08-08 16:16:45 2023-05-09 16:36:10 2023-03-14 16:36:21 2022-11-08 20:38:21
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 33M 30M 38M 28M 42M 45M 26M 23M 21M 36M 28M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 33M 30M 38M 28M 42M 45M 26M 23M 21M 36M 28M
netReceivables 55M 57M 52M 64M 58M 59M 66M 63M 67M 69M 76M
inventory 53M 0 48M 49M 43M 53M 57M 71M 67M 67M 61M
otherCurrentAssets 10M 62M 7M 12M 8M 12M 6M 6M 5M 9M 9M
totalCurrentAssets 151M 150M 145M 154M 151M 169M 168M 180M 172M 199M 186M
propertyPlantEquipmentNet 222M 0 258M 265M 270M 271M 272M 271M 267M 258M 246M
goodwill 0 0 0 0 0 0 6M 6M 6M 6M 6M
intangibleAssets 8M 8M 0 8M 8M 8M 9M 9M 9M 9M 9M
goodwillAndIntangibleAssets 8M 8M 8M 8M 8M 8M 15M 15M 15M 15M 15M
longTermInvestments 0 0 0 0 0 -1 0 0 0 0 0
taxAssets 0 0 0 0 0 9M 0 0 0 0 0
otherNonCurrentAssets 8M 235M 6M 5M 5M 6M 6M 6M 6M 6M 7M
totalNonCurrentAssets 238M 243M 272M 279M 284M 294M 293M 292M 288M 279M 268M
otherAssets 0 0 1 0 0 1 0 0 0 0 0
totalAssets 388M 393M 417M 432M 435M 463M 461M 471M 460M 478M 455M
accountPayables 16M 16M 17M 20M 19M 21M 24M 26M 24M 28M 17M
shortTermDebt 5M 5M 9M 9M 4M 4M 4M 4M 4M 4M 4M
taxPayables 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 0 0 17M 15M 0 0 0
otherCurrentLiabilities 22M 22M 19M 21M 32M 40M 14M 14M 26M 46M 33M
totalCurrentLiabilities 42M 43M 45M 50M 55M 65M 58M 59M 54M 78M 55M
longTermDebt 115M 134M 99M 108M 84M 82M 96M 103M 103M 83M 55M
deferredRevenueNonCurrent 0 0 0 0 0 19M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 9M 0 0 0 0 0
otherNonCurrentLiabilities 9M 9M 9M 9M 27M 8M 9M 9M 9M 9M 44M
totalNonCurrentLiabilities 124M 143M 108M 117M 111M 118M 105M 112M 112M 92M 65M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 19M 20M 20M 21M 18M 19M 24M 25M 24M 19M 13M
totalLiabilities 166M 185M 153M 167M 166M 183M 163M 171M 166M 170M 120M
preferredStock 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
commonStock 77 000 77 000 77 000 77 000 77 000 76 000 76 000 76 000 76 000 75 000 74 000
retainedEarnings -834M -847M -782M -779M -776M -764M -745M -741M -748M -735M -701M
accumulatedOtherComprehensiveIncomeLoss 5M 5M 2M 2M 2M 2M 2M 2M 2M 2M -284 000
othertotalStockholdersEquity 1 051M 1 050M 1 044M 1 043M 1 042M 1 041M 1 041M 1 040M 1 040M 1 041M 1 036M
totalStockholdersEquity 222M 208M 264M 266M 269M 280M 298M 301M 294M 308M 335M
totalEquity 222M 208M 264M 266M 269M 280M 298M 301M 294M 308M 335M
totalLiabilitiesAndStockholdersEquity 388M 393M 417M 432M 435M 463M 461M 471M 460M 478M 455M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 388M 393M 417M 432M 435M 463M 461M 471M 460M 478M 455M
totalInvestments 0 0 0 0 0 -1 0 0 0 0 0
totalDebt 120M 139M 104M 112M 106M 105M 100M 107M 107M 87M 59M
netDebt 87M 108M 70M 84M 64M 60M 74M 84M 86M 51M 30M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO ALTO
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164 778 164
fillingDate 2025-11-07 2025-08-08 2024-11-08 2024-08-08 2024-05-08 2024-03-14 2023-11-08 2023-08-08 2023-05-09 2023-03-14 2022-11-09
acceptedDate 2025-11-07 16:16:19 2025-08-08 16:11:46 2024-11-08 16:20:26 2024-08-08 16:35:14 2024-05-08 16:15:43 2024-03-14 06:20:03 2023-11-08 16:32:32 2023-08-08 16:16:45 2023-05-09 16:36:10 2023-03-14 16:36:21 2022-11-08 20:38:21
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2023 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome 14M -11M -2M -3M -12M -19M -3M 8M -13M -33M -28M
depreciationAndAmortization 6M 6M 6M 6M 6M 6M 6M 6M 6M 6M 6M
deferredIncomeTax 0 0 0 0 0 -4M -1M -959 000 0 0 0
stockBasedCompensation 0 626 000 862 000 2M 1M 1M 1M 959 000 752 000 787 000 767 000
changeInWorkingCapital 9M 5M 12M -10M 9M 4M 17M 3M -20M 51M -3M
accountsReceivables 3M 8M 12M -6M 675 000 7M -3M 3M 2M 8M 17M
inventory 2M -4M 1M -2M 9M 2M 14M -4M -519 000 -2M 1M
accountsPayables 5M 838 000 -1M -2M -2M -875 000 7M 5M -24M 31M -9M
otherWorkingCapital -1M 220 000 -522 000 109 000 691 000 -4M -2M -2M 3M 14M -12M
otherNonCashItems -6M -2M 2M 15M 2M 24M 4M -6M 3M -20M 5M
netCashProvidedByOperatingActivities 23M -848 000 19M -14M 1M 12M 23M 10M -23M 4M -19M
investmentsInPropertyPlantAndEquipment -2M -484 000 -491 000 -5M -5M -5M -7M -8M -10M -13M -15M
acquisitionsNet 0 -2M 3M -1M -1M 4M 0 0 -4M 15M -30 000
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 -2M -1M -1M -4M 0 0 0 -15M 15M
netCashUsedForInvestingActivites -2M -3M -91 000 -6M -6M -5M -7M -8M -13M -13M -735 000
debtRepayment -18M 7M -8M 6M -2M -5M -6M -2M 0 -15M 0
commonStockIssued 0 0 0 0 0 13M 0 2M 0 0 0
commonStockRepurchased 0 0 0 0 0 -991 000 0 -1M -2M -323 000 0
dividendsPaid -319 000 -315 000 -319 000 -316 000 -315 000 -319 000 -319 000 -315 000 -312 000 -319 000 -319 000
otherFinancingActivites 0 0 0 0 2M 10M -6M -2M 15M 41M -22M
netCashUsedProvidedByFinancingActivities -19M 7M -8M 6M 1M 4M -7M -3M 13M 25M -23M
effectOfForexChangesOnCash 0 0 0 0 0 -7M -8M 15M 0 0 0
netChangeInCash 3M 3M 10M -14M -3M 11M 10M -1M -23M 17M -42M
cashAtEndOfPeriod 33M 30M 38M 28M 42M 45M 35M 25M 26M 50M 32M
cashAtBeginningOfPeriod 30M 27M 28M 42M 45M 35M 25M 26M 50M 32M 75M
operatingCashFlow 23M -848 000 19M -14M 1M 12M 23M 10M -23M 4M -19M
capitalExpenditure -2M -484 000 -491 000 -5M -5M -5M -7M -8M -10M -13M -15M
freeCashFlow 21M -1M 18M -18M -3M 7M 16M 2M -33M -8M -34M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q3
2025-11-05 ET (fiscal 2025 q3)
2025 q2
2025-08-06 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-03-05 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-09 ET (fiscal 2024 q2)
2024 q1
2024-05-06 ET (fiscal 2024 q1)
2023 q4
2024-03-11 ET (fiscal 2023 q4)
2023 q3
2023-11-06 ET (fiscal 2023 q3)
2023 q2
2023-08-07 ET (fiscal 2023 q2)
2023 q1
2023-05-08 ET (fiscal 2023 q1)
2022 q4
2023-03-09 ET (fiscal 2022 q4)
2022 q3
2022-11-07 ET (fiscal 2022 q3)
2022 q2
2022-08-08 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2025-11-05 16:15 ET
Alto Ingredients reported for 2025 q3
SEC form 8
2025-11-05 16:15 ET
Alto Ingredients published news for 2025 q3
SEC form 10
2025-08-08 16:11 ET
Alto Ingredients reported for 2025 q2
SEC form 8
2025-08-06 20:19 ET
Alto Ingredients reported for 2025 q2
SEC form 8
2025-08-06 20:19 ET
Alto Ingredients published news for 2025 q2
SEC form 10
2025-05-09 20:16 ET
Alto Ingredients published news for 2025 q1
SEC form 10
2025-05-09 00:00 ET
Alto Ingredients published news for 2025 q1
SEC form 8
2025-05-07 20:14 ET
Alto Ingredients published news for 2025 q1
SEC form 8
2025-05-07 20:14 ET
Alto Ingredients reported for 2025 q1
SEC form 10
2025-03-13 20:15 ET
Alto Ingredients published news for 2024 q4
SEC form 10
2025-03-13 00:00 ET
Alto Ingredients published news for 2024 q4
SEC form 8
2025-03-05 16:15 ET
Alto Ingredients published news for 2024 q4
SEC form 8
2025-03-05 16:15 ET
Alto Ingredients reported for 2024 q4
SEC form 10
2024-11-08 16:20 ET
Alto Ingredients published news for 2024 q3
SEC form 8
2024-11-06 16:19 ET
Alto Ingredients published news for 2024 q3
SEC form 8
2024-11-06 16:19 ET
Alto Ingredients published news for 2024 q3
SEC form 10
2024-08-08 00:00 ET
Alto Ingredients published news for 2024 q2
SEC form 8
2024-08-06 16:21 ET
Alto Ingredients published news for 2024 q2
SEC form 8
2024-08-06 16:21 ET
Alto Ingredients reported for 2024 q2
SEC form 10
2024-05-08 00:00 ET
Alto Ingredients published news for 2024 q1
SEC form 8
2024-05-06 16:13 ET
Alto Ingredients published news for 2024 q1
SEC form 8
2024-05-06 16:13 ET
Alto Ingredients reported for 2024 q1
SEC form 10
2024-03-14 06:20 ET
Alto Ingredients published news for 2023 q4
SEC form 10
2024-03-14 00:00 ET
Alto Ingredients published news for 2023 q4
SEC form 8
2024-03-11 16:18 ET
Alto Ingredients published news for 2023 q4
SEC form 8
2024-03-11 16:18 ET
Alto Ingredients reported for 2023 q4
SEC form 10
2023-11-08 00:00 ET
Alto Ingredients published news for 2023 q3
SEC form 8
2023-11-06 16:19 ET
Alto Ingredients reported for 2023 q3
SEC form 10
2023-08-08 16:16 ET
Alto Ingredients published news for 2023 q2
SEC form 10
2023-08-08 00:00 ET
Alto Ingredients published news for 2023 q2
SEC form 6
2023-08-07 16:15 ET
Alto Ingredients reported for 2023 q2
SEC form 8
2023-08-07 00:00 ET
Alto Ingredients published news for 2023 q2
SEC form 6
2023-06-22 16:26 ET
Alto Ingredients published news for 2023 q1
SEC form 10
2023-05-09 00:00 ET
Alto Ingredients published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
Alto Ingredients published news for 2023 q1
SEC form 10
2023-03-14 00:00 ET
Alto Ingredients reported for 2022 q4
SEC form 8
2023-03-09 00:00 ET
Alto Ingredients reported for 2022 q4
SEC form 10
2022-11-09 00:00 ET
Alto Ingredients reported for 2022 q3
SEC form 8
2022-11-07 00:00 ET
Alto Ingredients reported for 2022 q3
SEC form 10
2022-08-09 00:00 ET
Alto Ingredients reported for 2022 q2
SEC form 8
2022-08-08 00:00 ET
Alto Ingredients reported for 2022 q2
SEC form 10
2022-05-10 00:00 ET
Alto Ingredients reported for 2022 q1
SEC form 8
2022-05-09 00:00 ET
Alto Ingredients reported for 2022 q1
SEC form 10
2022-03-15 00:00 ET
Alto Ingredients published news for 2021 q4
SEC form 8
2022-03-10 00:00 ET
Alto Ingredients published news for 2021 q4
SEC form 10
2021-11-12 00:00 ET
Alto Ingredients published news for 2021 q3
SEC form 8
2021-11-09 00:00 ET
Alto Ingredients published news for 2021 q3
SEC form 10
2021-08-10 00:00 ET
Alto Ingredients published news for 2021 q2
SEC form 10
2021-05-17 00:00 ET
Alto Ingredients published news for 2021 q1